Equillium Inc (EQ)
0.7096
+0.03
(+3.71%)
USD |
NASDAQ |
Nov 15, 16:00
0.7048
0.00 (0.00%)
After-Hours: 20:00
Equillium Research and Development Expense (TTM): 38.71M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 38.71M |
| March 31, 2024 | 37.51M |
| December 31, 2023 | 37.04M |
| September 30, 2023 | 36.38M |
| June 30, 2023 | 36.18M |
| March 31, 2023 | 36.06M |
| December 31, 2022 | 37.55M |
| September 30, 2022 | 36.57M |
| June 30, 2022 | 34.76M |
| March 31, 2022 | 31.26M |
| December 31, 2021 | 26.38M |
| September 30, 2021 | 25.40M |
| June 30, 2021 | 22.65M |
| Date | Value |
|---|---|
| March 31, 2021 | 20.56M |
| December 31, 2020 | 19.38M |
| September 30, 2020 | 18.27M |
| June 30, 2020 | 18.23M |
| March 31, 2020 | 18.59M |
| December 31, 2019 | 17.64M |
| September 30, 2019 | 14.71M |
| June 30, 2019 | 11.75M |
| March 31, 2019 | 8.039M |
| December 31, 2018 | 4.943M |
| September 30, 2018 | 2.907M |
| June 30, 2018 | 1.735M |
| March 31, 2018 | 1.997M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.64M
Minimum
Dec 2019
38.71M
Maximum
Jun 2024
28.90M
Average
31.26M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| Matinas BioPharma Holdings Inc | 13.78M |
| Tenon Medical Inc | 2.805M |
| Alphatec Holdings Inc | 79.76M |
| Madrigal Pharmaceuticals Inc | 281.71M |
| Spero Therapeutics Inc | 74.01M |